Ikena Oncology, Inmagene Biopharmaceuticals appoint Kristin Yarema, as CEO Ikena Oncology, Inmagene Biopharmaceuticals appoint Kristin Yarema, as CEO Post ContentiknaRead More You might also be interested in reading Maven 11 Capital raise $120M in secondary funding round. July 23, 2025 In Mainstream ← Previous post Next post →